Article
KMT2C is Potential Prognostic Biomarker and its Immune Regulating Roles in Pan-Cancer: A Comprehensive Analysis
2021-12-22
Abstract excerpt
<h4>Background: </h4> A member of histone lysine methyltransferases subfamily, The histone 3 lysine 4 (H3K4) monomethylase KMT2C, has mutations across many cancer types. However, the role of KMT2C in different cancers and its correlation with tumor infiltration and immune therapy indicators remain unknown. <h4>Method: </h4> Expression and mutation information of KMT2C has been analyzed through the Genotype-Tissue...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e3a89932-becd-56cb-9eb2-e9ee039aad15
- DOI
- 10.21203/rs.3.rs-1174621/v1
